IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgic...
Imris reported revenue of $28.89 million for fiscal year 2014, down 37.3% from fiscal year 2013, and net income of -$30.39 million.
Figures from company filings; latest fiscal year ended December 31, 2014.
No profile data available.